TCA
ZBH icon

Transcend Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

Transcend Capital Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,584
Closed -$203K – 551
2022
Q1 		$203K Buy
+1,584
New +$191K 0.02% 479

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Transcend Capital Advisors's ZBH Position: Q2 2022 in Review

Transcend Capital Advisors sold out of Zimmer Biomet (ZBH) in Q2 2022, closing a stake of 1,584 shares — an estimated $203K sold.

Transcend Capital Advisors first reported a position in ZBH in Q1 2022 and held it in 1 quarter. The position peaked at $203K in Q1 2022. 956 funds tracked by Wall St. Rank hold ZBH as of Q2 2022.

  • Transcend Capital Advisors reported no remaining Zimmer Biomet position as of Q2 2022 after selling out during the quarter.
  • Transcend Capital Advisors sold 1,584 Zimmer Biomet shares in Q2 2022, an estimated $203K.
  • Transcend Capital Advisors first reported a position in Zimmer Biomet in Q1 2022 and held it in 1 quarter.
  • Transcend Capital Advisors's Zimmer Biomet position peaked at $203K in Q1 2022.
  • 956 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2022.

Based on Transcend Capital Advisors's 13F filing for Q2 2022, filed 12 Jul 2022.